EP. 1: Are your Therapies Getting to the Patients that Need Them? It May be Time to Reframe your Market Access Strategy.ByBrian Corvino, Brand Insights Contributor, Managing Director, Deloitte Consulting, LLP and Value, Access, Pricing Practice Leader,John Jaeger, Brand Insights Contributor, Managing Director, Deloitte Consulting LLPFebruary 28th 2022
EP. 2: Value/Access/Pricing: An essential enabler for delivering on the promise of oncology innovation ByJoseph M. Coppola, Brand Insights Contributor, Managing Director, Commercial and Market Access Leader, Deloitte Consulting LLP,Brian Corvino, Brand Insights Contributor, Managing Director, Deloitte Consulting, LLP and Value, Access, Pricing Practice LeaderSeptember 20th 2021
EP. 3: Pharmaceutical Product Pricing and Contracts Lifecycle Management: The Importance of Linking Strategy and OperationsByJoseph M. Coppola, Brand Insights Contributor, Managing Director, Commercial and Market Access Leader, Deloitte Consulting LLP,Brian Corvino, Brand Insights Contributor, Managing Director, Deloitte Consulting, LLP and Value, Access, Pricing Practice LeaderJune 12th 2021
EP. 4: The Pandemic Didn’t Hinder Drug Launches, but it Has Altered Sales TacticsByBrian Corvino, Brand Insights Contributor, Managing Director, Deloitte Consulting, LLP and Value, Access, Pricing Practice Leader,Candy Lurken, Brand Insights Contributor, Principal, Deloitte Consulting, LLPMay 11th 2021
